药物对比
Galcanezumab vs Rimegepant
比较 Galcanezumab 与 Rimegepant 治疗偏头痛：注射用 CGRP 单克隆抗体 vs 口服 CGRP 拮抗剂。主要差异在于用途、给药途径和适应症。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when selecting CGRP-targeted therapies for migraine prevention or considering oral versus injectable options.
结论
Galcanezumab and Rimegepant are both CGRP-targeting migraine treatments but differ in administration, approved uses, and the better choice depends on patient-specific needs.
全部药物对比